cisplatin

February 19, 2018February 19, 2018

Opdivo Safe for Head and Neck Cancer Patients on Radiation and Chemo, Phase 1 Trial Shows

News

Adding Bristol-Myers-Squibb‘s Opdivo (nivolumab) to a regimen of radiation therapy and chemotherapy is safe in patients with newly diagnosed advanced head and neck cancer, a Phase 1 clinical trial shows. Researchers presented ... Read more

February 13, 2018February 13, 2018

Targovax Therapy and Chemo Trigger Immune Response to Mesothelioma, Phase 1/2 Trial Shows

News

ONCOS-102 triggered an immune response against mesothelioma and was safe, the initial results of a Phase 1/2 clinical trial of a combo therapy shows. Targovax designed its virus-based ONCOS-102 to strengthen ... Read more

April 19, 2016April 19, 2016

Immunotherapy in Combo with Chemotherapy Seen to Improve Response Rates in Malignant Pleural Mesothelioma Patients

News

The combined use of immunotherapy with live bacterium and chemotherapy improves the response rate in patients with malignant pleural mesothelioma (MPM), according to the results of a Phase 1b ... Read more

February 3, 2015February 3, 2015

Immunotherapy Found To Enhance CD4 T Cell Responses In Tumor Microenvironment

News

In a recent study, titled “Cancer Immunotherapy Employing an Innovative Strategy to Enhance CD4+ T Cell Help in the Tumor Microenvironment”, published in PlosOne, a research team from Johns ... Read more

Pin It on Pinterest